GENOMMA LAB INT. FIN. B
GENOMMA LAB INT. FIN. B
Share · MX01LA010006 · A0Q4TC (XMEX)
Overview
No Price
15.12.2025 08:09
Current Prices from GENOMMA LAB INT. FIN. B
ExchangeTickerCurrencyLast TradePriceDaily Change
XFRA: Frankfurt
Frankfurt
GEKA.F
EUR
15.12.2025 08:09
0,87 EUR
0,00 EUR
XDQU: Quotrix
Quotrix
GLISAA06.DUSD
EUR
15.12.2025 06:27
0,89 EUR
0,03 EUR
+2,89 %
XDUS: Düsseldorf
Düsseldorf
GLISAA06.DUSB
EUR
11.12.2025 18:32
0,88 EUR
0,02 EUR
+1,74 %
OTC: UTC
UTC
GNMLF
USD
08.12.2025 21:00
0,96 USD
0,00 USD
Invested Funds

The following funds have invested in GENOMMA LAB INT. FIN. B:

Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
169,78
Percentage (%)
0,01 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
33,54
Percentage (%)
0,01 %
Company Profile for GENOMMA LAB INT. FIN. B Share
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
Get up to date insights from finAgent about GENOMMA LAB INT. FIN. B

Company Data

Name GENOMMA LAB INT. FIN. B
Company Genomma Lab Internacional, S.A.B. de C.V.
Website https://www.genommalab.com
Primary Exchange XMEX BOLSA MEXICANA DE VALORES (MEXICAN STOCK EXCHANGE)
WKN A0Q4TC
ISIN MX01LA010006
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Juan Marco Sparvieri
Market Capitalization 959 Mio
Country Mexico
Currency EUR
Employees 1,6 T
Address Av. Antonio Dovalí Jaime no.70, 01210 Mexico City
IPO Date 2012-05-04

Ticker Symbols

Name Symbol
Over The Counter GNMLF
Düsseldorf GLISAA06.DUSB
Frankfurt GEKA.F
Quotrix GLISAA06.DUSD
More Shares
Investors who hold GENOMMA LAB INT. FIN. B also have the following shares in their portfolio:
0LND.SG
0LND.SG Unbekannt
AIR PRODUCTS & CHEMICALS INC
AIR PRODUCTS & CHEMICALS INC Share
AVANTIUM NV    EO -,10
AVANTIUM NV EO -,10 Share
DANAHER CORP
DANAHER CORP Share
FASTLY INC CL.ADL-,00002
FASTLY INC CL.ADL-,00002 Share
ISHARES TECDAX UCITS ETF
ISHARES TECDAX UCITS ETF ETF
KONINKL. PHILIPS ADR -,20
KONINKL. PHILIPS ADR -,20 Depository Receipt
L.K. TECH.S
L.K. TECH.S Share
MEDICAL PROPERTIES TR.
MEDICAL PROPERTIES TR. Fund
SFC ENERGY AG
SFC ENERGY AG Share
STEICO SE
STEICO SE Share
TEXAS INSTRUMENTS INC
TEXAS INSTRUMENTS INC Share
THE REPUBLIC OF ZAMBIA 5.375% NTS 20/09/22 144A
THE REPUBLIC OF ZAMBIA 5.375% NTS 20/09/22 144A Bond
XIAOMI CORP CL.B
XIAOMI CORP CL.B Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025